HCM
KDNY
Highbridge Capital Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-110,000
| Closed | -$4.23M | – | 464 |
|
|
2023
Q2 | $4.23M | Buy |
+110,000
| New | +$4.23M | 0.19% | 74 |
|
|
2017
Q3 | – | Sell |
-25,770
| Closed | -$294K | – | 1191 |
|
|
2017
Q2 | $294K | Sell |
25,770
-53,565
| -68% | -$611K | ﹤0.01% | 664 |
|
|
2017
Q1 | $853K | Buy |
+79,335
| New | +$853K | 0.01% | 561 |
|